Back to results
US 8,283,382 B2Granted
Vitamin K for prevention and treatment of skin rash secondary to anti-EGFR therapy
AssigneeAlbert Einstein College of Medicine of Yeshiva University
InventorsRoman Perez-Soler, Yi-He Ling
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions for treating and preventing a skin rash secondary to anti-epidermal growth factor receptor (EGFR) therapy, where the method comprises applying a vitamin K analog or a phosphatase inhibitor to the skin.
Claims10
A method for reducing the likelihood of developing a skin rash secondary to an anti-epidermal growth factor (EGFR) therapy in a subject in need of the therapy, the method comprising applying vitamin K3 to the skin of the subject prior to occurrence of the rash in an amount effective to reduce development of the rash.
Dependencies are inferred from the claim text.